Quartett Biotechnologie GmbHH4.E19Founded 1986 in Berlin/Germany as a family-run biotechnology company quartett is committed to the fight against cancer and wants to contribute better cancer diagnosis.
Our first manufacturing site was founded in 1997. In 2023, we moved into our new company building including an area of 800 sqm laboratory space. Our certified production site (ISO 9001, ISO 13485, IVDR) guarantees products of highest quality. All products are solely developed and manufactured in Germany.
Specialized in two areas, we produce monoclonal antibodies for anatomic pathology as well as synthetic peptides for the pharmaceutical industry and research.
The company specialized its product profile in the development and production of recombinant rabbit monoclonal antibodies for anatomic pathology as well as ancillary IHC reagents optimized for any automated staining platform and manual staining. Second expertise is the production and modification of purely synthetic peptides with HPLC purity > 95 % (protease inhibitors, peptides for antibody production).
